Non-invasive markers of liver fibrosis scores, including aspartate aminotransferase/alanine aminotransferase ratio, NAFLD fibrosis score, BARD score, and aspartate aminotransferase to platelet ratio index, have been used to evaluate the improvement of NAFLD after SG [56]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.